Loading clinical trials...
Loading clinical trials...
A Prospective, Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation
This study will evaluate the safety and effectiveness of the Globe® Pulsed Field System for treating patients with symptomatic paroxysmal or persistent atrial fibrillation (AF).
Age
18 - 80 years
Sex
ALL
Healthy Volunteers
No
Grandview Medical Center
Birmingham, Alabama, United States
St. Bernards Medical Center
Jonesboro, Arkansas, United States
Sutter Health - California Pacific Medical Center
San Francisco, California, United States
St. Vincent's Medical Center
Jacksonville, Florida, United States
Mercy Hospital
Miami, Florida, United States
Johns Hopkins
Baltimore, Maryland, United States
Beaumont Hospital
Royal Oak, Michigan, United States
Mt. Sinai Hospital, Guggenheim Pavilion
New York, New York, United States
Cleveland Clinic
Cleveland, Ohio, United States
Doylestown Hospital
Doylestown, Pennsylvania, United States
Start Date
March 9, 2023
Primary Completion Date
September 1, 2026
Completion Date
September 1, 2026
Last Updated
January 30, 2026
549
ESTIMATED participants
Globe Pulsed Field System
DEVICE
Lead Sponsor
Kardium Inc.
NCT03546374
NCT07301190
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07281898